| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | X8Y5U6NC7E |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Angiopoietin-1 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Fallopian Tube Neoplasms | 3 | D005185 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Peritoneal Neoplasms | 3 | D010534 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Gliosarcoma | 2 | D018316 | ClinicalTrials |
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108568 |
| FDA SRS | X8Y5U6NC7E |
CONTENTS